IP Rights in Orphaned and Rare Diseases
John Crowley, CEO of Amicus Pharmaceuticals and Notre Dame Law School Alumnus, will be speaking about the IP rights important to the field of orphaned and rare diseases.
Sponsors: Intellectual Property Law Society and Health Law Society